These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34244016)

  • 1. Cancer of the Oropharynx and the Association with Human Papillomavirus.
    Rettig EM; Sethi RKV
    Hematol Oncol Clin North Am; 2021 Oct; 35(5):913-931. PubMed ID: 34244016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.
    Chau NG; Rabinowits G; Haddad RI
    Curr Treat Options Oncol; 2014 Dec; 15(4):595-610. PubMed ID: 25240410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
    Fung N; Faraji F; Kang H; Fakhry C
    Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Good cancer gone bad': a narrative review of HPV oropharyngeal cancer and potential poor outcomes.
    Alabi O; O'Neill JP
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2185-2191. PubMed ID: 32333138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative Treatment of Oropharyngeal Cancer in the Era of Human Papillomavirus.
    Geiger JL; Ku JA
    Curr Treat Options Oncol; 2019 Feb; 20(3):20. PubMed ID: 30771020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.
    Maxwell JH; Grandis JR; Ferris RL
    Annu Rev Med; 2016; 67():91-101. PubMed ID: 26332002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV-related cancer: A retrospective cohort study.
    De Cicco R; de Melo Menezes R; Nicolau UR; Pinto CAL; Villa LL; Kowalski LP
    Head Neck; 2020 Jan; 42(1):93-102. PubMed ID: 31633252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
    Ang KK; Sturgis EM
    Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Special Issue about Head and Neck Cancers: HPV Positive Cancers.
    Economopoulou P; Kotsantis I; Psyrri A
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
    Liederbach E; Kyrillos A; Wang CH; Liu JC; Sturgis EM; Bhayani MK
    Int J Cancer; 2017 Feb; 140(3):504-512. PubMed ID: 27667729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
    Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
    Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV positive oropharyngeal cancer and treatment deintensification: how pertinent is it?
    Laskar SG; Swain M
    J Cancer Res Ther; 2015; 11(1):6-9. PubMed ID: 25879328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer.
    Mehra R; Ang KK; Burtness B
    Semin Radiat Oncol; 2012 Jul; 22(3):194-7. PubMed ID: 22687943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
    O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
    J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of human papilloma virus associated oropharyngeal squamous cell carcinoma and its impact on diagnosis, prognostication, and response assessment.
    Touska P; Connor S
    Br J Radiol; 2022 Sep; 95(1138):20220149. PubMed ID: 35687667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.
    Hanna GJ; Lau CJ; Mahmood U; Supplee JG; Mogili AR; Haddad RI; Jänne PA; Paweletz CP
    Oral Oncol; 2019 Aug; 95():120-126. PubMed ID: 31345379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment deintensification in human papillomavirus-positive oropharynx cancer: Outcomes from the National Cancer Data Base.
    Cheraghlou S; Yu PK; Otremba MD; Park HS; Bhatia A; Zogg CK; Mehra S; Yarbrough WG; Judson BL
    Cancer; 2018 Feb; 124(4):717-726. PubMed ID: 29243245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What every dentist needs to know about human papillomavirus.
    Henry JK; Votolato GS; Brooks JK; Abbas FM; Bashirelahi N
    Gen Dent; 2021; 69(2):23-27. PubMed ID: 33661110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.